Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 127105, 7 pages
http://dx.doi.org/10.1155/2013/127105
Research Article

Inhibitory Action of Quercetin on Eosinophil Activation In Vitro

1Graduate School of Nursing and Rehabilitation Sciences, Showa University Graduate School, Yokohama, Kanagawa 226-8555, Japan
2Bio-Thera Clinic, Shinjuku, Tokyo 162-0022, Japan
3Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, Yokohama, Kanagawa 226-8555, Japan

Received 11 March 2013; Revised 15 May 2013; Accepted 22 May 2013

Academic Editor: Tanawan Kummalue

Copyright © 2013 Misako Sakai-Kashiwabara and Kazuhito Asano. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Pawankar, S. Mori, C. Ozu, and S. Kimura, “Overview on the pathomechanisms of allergic rhinitis,” Asia Pacific Allergy, vol. 1, no. 3, pp. 157–167, 2011. View at Publisher · View at Google Scholar
  2. D. H. Broide, “Allergic rhinitis: pathophysiology,” Allergy and Asthma Proceedings, vol. 31, no. 5, pp. 370–374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. Kay, “The role of eosinophils in the pathogenesis of asthma,” Trends in Molecular Medicine, vol. 11, no. 4, pp. 148–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. Erjefält, L. Greiff, M. Andersson et al., “Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 1, pp. 304–312, 1999. View at Google Scholar · View at Scopus
  5. S. G. Trivedi and C. M. Lloyd, “Eosinophils in the pathogenesis of allergic airways disease,” Cellular and Molecular Life Sciences, vol. 64, no. 10, pp. 1269–1289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Google Scholar · View at Scopus
  7. N. Kawada, S. Seki, M. Inoue, and T. Kuroki, “Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells,” Hepatology, vol. 27, no. 5, pp. 1265–1274, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Middleton Jr., “Effect of plant flavonoids on immune and inflammatory cell function,” Advances in Experimental Medicine and Biology, vol. 439, pp. 175–182, 1998. View at Google Scholar · View at Scopus
  9. Y. D. Min, C. H. Choi, H. Bark et al., “Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-κB and p38 MAPK in HMC-1 human mast cell line,” Inflammation Research, vol. 56, no. 5, pp. 210–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. P. Rogerio, A. Kanashiro, C. Fontanari et al., “Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma,” Inflammation Research, vol. 56, no. 10, pp. 402–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Dorsch, M. Bittinger, A. Kaas, A. Muller, B. Kreher, and H. Wagner, “Antiasthmatic effects of Galphimia glauca, gallic acid, and related compounds prevent allergen- and platelet-activating factor-induced bronchial obstruction as well as bronchial hyperreactivity in guinea pigs,” International Archives of Allergy and Immunology, vol. 97, no. 1, pp. 1–7, 1992. View at Google Scholar · View at Scopus
  12. K. Asano, K. Sugimoto, T. Watanabe, M. Hisano, and T. Hisamitsu, “Suppressive effects of the Chinese herbal remedy Tripterygium wilfordii Hook f on eosinophilia and IgE hyperproduction in mice,” Allergology International, vol. 49, no. 1, pp. 37–45, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Dold, J. Heinrich, H. Wichmann, and M. Wjst, “Ascans-specific IgE and allergic sensitization in a cohort of school children in the former East Germany,” Journal of Allergy and Clinical Immunology, vol. 102, no. 3, pp. 414–420, 1998. View at Google Scholar · View at Scopus
  14. Y. Mochizuki, A. Furuta, A. Furuya, K. Kanai, K. Asano, and H. Suzaki, “Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro,” In Vivo, vol. 22, no. 1, pp. 13–20, 2008. View at Google Scholar · View at Scopus
  15. M. Malm-Erjefält, C. G. A. Persson, and J. S. Erjefält, “Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 24, no. 3, pp. 352–359, 2001. View at Google Scholar · View at Scopus
  16. Y. Kusama, M. Takamoto, T. Kasahara, K. Takatsu, H. Nariuchi, and K. Sugane, “Mechanisms of eosinophilia in BALB/c-nu/+ and congenitally athymic BALB/c-nu/nu mice infected with Toxocara canis,” Immunology, vol. 84, no. 3, pp. 461–468, 1995. View at Google Scholar · View at Scopus
  17. M. Takamoto, Z.-X. Wang, N. Watanabe, A. Matsuzawa, H. Nariuchi, and K. Sugane, “Eosinophilia, IgE production, and cytokine production by lung T cells in surface CD4-deficient mutant mice infected with Toxocara canis,” Immunology, vol. 95, no. 1, pp. 97–104, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. L. A. Dent, C. M. Daly, G. Mayrhofer et al., “Interleukin-5 transgenic mice show enhanced resistance to primary infections with Nippostrongylus brasiliensis but not primary infections with Toxocara canis,” Infection and Immunity, vol. 67, no. 2, pp. 989–993, 1999. View at Google Scholar · View at Scopus
  19. K. Kanai, K. Asano, T. Hisamitsu, and H. Suzaki, “Suppressive activity of epinastine hydrochloride on TARC production from human peripheral blood CD4+ T cells in-vitro,” Journal of Pharmacy and Pharmacology, vol. 57, no. 8, pp. 1027–1035, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kanai, K. Asano, S. Watanabe, Y. Kyo, and H. Suzaki, “Epinastine hydrochloride antagonism against interleukin-4-mediated T cell cytokine imbalance in vitro,” International Archives of Allergy and Immunology, vol. 140, no. 1, pp. 43–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. de Pascual-Teresa, K. L. Johnston, M. S. DuPont et al., “Quercetin metabolites downregulate cydooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo,” Journal of Nutrition, vol. 134, no. 3, pp. 552–557, 2004. View at Google Scholar · View at Scopus
  22. D. C. Nieman, D. A. Henson, J. M. Davis et al., “Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA,” Journal of Applied Physiology, vol. 103, no. 5, pp. 1728–1735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Okayama and T. Kawakami, “Development, migration, and survival of mast cells,” Immunologic Research, vol. 34, no. 2, pp. 97–115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. P. Oliveira, D. D. Taub, J. Nagel et al., “Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis,” Blood, vol. 100, no. 13, pp. 4291–4297, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. H. F. Rosenberg, S. Phipps, and P. S. Foster, “Eosinophil trafficking in allergy and asthma,” Journal of Allergy and Clinical Immunology, vol. 119, no. 6, pp. 1303–1310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Haelens, A. Wuyts, P. Proost, S. Struyf, G. Opdenakker, and J. Van Damme, “Leukocyte migration and activation by murine chemokines,” Immunobiology, vol. 195, no. 4-5, pp. 499–521, 1996. View at Google Scholar · View at Scopus
  27. S. H. P. Oliveira, S. Lira, C. Martinez-A, M. Wiekowski, L. Sullivan, and N. W. Lukacs, “Increased responsiveness of murine eosinophils to MIP-1β (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8,” Journal of Leukocyte Biology, vol. 71, no. 6, pp. 1019–1025, 2002. View at Google Scholar · View at Scopus
  28. L. Rönnstrand, “Signal transduction via the stem cell factor receptor/c-Kit,” Cellular and Molecular Life Sciences, vol. 61, no. 19-20, pp. 2535–2548, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. H. Kim, C. H. Choi, S. Y. Kim, J. S. Eun, and T. Y. Shin, “Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model,” Experimental Biology and Medicine, vol. 230, no. 1, pp. 82–88, 2005. View at Google Scholar · View at Scopus
  30. M. E. J. Lean, M. Noroozi, I. Kelly et al., “Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA,” Diabetes, vol. 48, no. 1, pp. 176–181, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. D. A. Shoskes, S. I. Zeitlin, A. Shahed, and J. Rajfer, “Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial,” Urology, vol. 54, no. 6, pp. 960–963, 1999. View at Google Scholar · View at Scopus
  32. J. C. Chen, F. M. Ho, P. D. L. Chao et al., “Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IκB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia,” European Journal of Pharmacology, vol. 521, no. 1–3, pp. 9–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. R. A. Walgren, U. K. Walle, and T. Walle, “Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells,” Biochemical Pharmacology, vol. 55, no. 10, pp. 1721–1727, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. P. C. H. Hollman, M. V. D. Gaag, M. J. B. Mengelers, J. M. P. Van Trijp, J. H. M. De Vries, and M. B. Katan, “Absorption and disposition kinetics of the dietary antioxidant quercetin in man,” Free Radical Biology and Medicine, vol. 21, no. 5, pp. 703–707, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. T. L. Wadsworth and D. R. Koop, “Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide,” Chemico-Biological Interactions, vol. 137, no. 1, pp. 43–58, 2001. View at Publisher · View at Google Scholar · View at Scopus